Abstract
In this chapter we give an overview on QSAR models for treating the mutagenicity of cyclic amines. An extensive discussion is focused on the topological, E-state, quantum chemical, and empirical descriptors (logP) that are often used in corresponding models. Two case studies are presented in more detail. The conclusion addresses the OECD principles for validation of models that are used for regulatory purposes.
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- (Q)SAR:
-
(Quantitative) structure–activity relationship
- E HOMO :
-
Energy of the highest occupied orbital
- E LUMO :
-
Energy of the lowest unoccupied orbital
- 2D, 3D:
-
Two dimensional, Three dimensional
- OECD:
-
Organization for economic cooperation and development
References
Benigni R, Giuliani A, Franke R, Gruska A (2000) Chem Rev 100:3697
McCann J, Choi E, Yamasaki E, Ames BN (1975) Proc Natl Acad Sci USA 72:5135
Zeiger E (2001) Mutat Res 492:29
Dolin PJ (1992) Br J Cancer 65:476
Vincis P, Pirastu R (1997) Cancer Cause Control 8:346
Kinosita R (1937) Tr Soc Path Jap 27:665
Benigni R, Giuliani A, Gruska A, Franke R (2003) QSARs for the mutagenicity and carcinogenicity of the aromatic amines. In: Benigni R (ed) Quantitative structure–activity relationship (QSAR) models of mutagens and carcinogens. CRC, Boca Raton FL, p 125
Benigni R (2005) Chem Rev 105:1767
Klopman G, Frierson MR, Rosenkranz HS (1985) Environ Mutagen 7:625
Zhang YP, Klopman G, Rosenkranz HS (1993) Environ Mol Mutagen 21:100
Glende C, Klein M, Schmitt H, Erdinger L, Boche G (2002) Mutat Res 515:15
Debnath AK, Debnath G, Shusterman AJ, Hansh C (1992) Environ Mol Mutagen 19:37
Garg A, Bhat KL, Bock CW (2002) Dyes Pigments 55:35
CODESSATM, v20, Semichem, 7204 Mullen, Shawnee KS 66216, USA
Gramatica P, Connsonni V, Pavan M (2003) SAR QSAR Environ Res 14:237
Todeschini R, Consonni V, Mauri A, Pavan M (2002) DRAGON rel 2.1 for Windows, Milano, Italy
Todeschini R, Mauri A (2000) DOLPHIN rel 2.1 for Windows, Milano, Italy
Leardi R, Boggia R, Terrile M (1992) J Chemom 6:267
Chung KT, Chen SC, Wong TY, Li YS, Wei CI, Chou MW (2000) Toxicol Sci 56:351
Hatch FT, Lightstone, Colvin ME (2000) Environ Mol Mutagen 35:279
Patlewicz G, Rodford R, Walker JD (2003) Environ Toxicol Chem 22:1885
Votano JR, Parham M, Hall LH, Kier LB, Oloff S, Tropsha A, Xie Q, Tong W (2004) Mutagenesis 19:365
Lozano JJ, Pastor M, Cruciani G, Gaedt K, Centeno NB, Gago F, Sanz F (2000) J Comput Aid Mol Des 14:341
Mattioni BE, Kauffman GW, Jurs PC, Custer LL, Durham SK, Pearl GM (2003) J Chem Inf Comput Sci 43:949
Contrera JF, Matthews EJ, Kruhlak NL, Benz RD (2005) Regul Toxicol Pharmacol 43:313
Zupan J, Vračko M, Novič M (2000) Acta Chim Slov 47:11
Todeschini R, Consonni V (2000) The handbook of molecular descriptors. Wiley, New York
Schuur JH, Selzer P, Gasteiger J (1996) J Chem Inf Comput Sci 36:334
Diudea MV (ed) (2001) QSPR/QSAR studies by molecular descriptors. Nova Science, Hungtington, New York
Basak SC, Mills D (2001) SAR QSAR Environ Res 12:481
Wiener H (1947) J Am Chem Soc 69:2636
Balaban A (2001) A personal view about topological indices for QSAR/QSPR. In: Diudea MV (ed) QSPR/QSAR studies by molecular descriptors. Nova Science, Hungtington, New York
Devillers J, Balaban AT (eds) (1999) Topological indices and related descriptors in QSAR and QSPR. Gordon and Breach, Reading, UK
Randić M (1998) Topological indices. In: Schleyer PvR, Allinger NL, Clark T, Gasteiger J, Kollman PA, Schaefer III HF, Schreiner PR (eds) Encyclopedia of computational chemistry. Wiley, Chichester
Netzeva TI (2004) Whole molecule and atom-based topological descriptors. In: Cronin MTD (ed) Predicting chemical toxicity and fate. CRC, Boca Raton FL
Randič M (1975) J Am Chem Soc 97:6609
Randič M (2001) J Mol Graphics Modelling 20:19
Kier LB, Hall LH (1976) J Pharm Sci 65:1806
Rose K, Hall LH, Kier LB (2002) J Chem Inf Comput Sci 42:651
Katritzky AR, Lobanov VS, Karelson M (1994) CODESSA Reference manual 2.0, Gainesville
Rohrbaugh RH, Jurs PC (1987) Anal Chim Acta 199:99
Randić M, Razinger M (1997) On characterization of 3D molecular structure. In: Balaban AT (ed) From chemical topology to three-dimensional structure. Plenum, New York
Thouless DJ (1972) The quantum mechanics of many-body systems. Academic, New York
Schaefer III HF (1977) Methods of electronic structure theory. Plenum, New York
Hehre WJ, Radom L, Schleyer PR, Pople JA (1986) Ab initio molecular orbital theory. Wiley, New York
Murrell JN, Herget AJ (1972) Semi-empirical self-consistent-field-molecular theory of molecules. Wiley, New York
Koopmans T (1934) Physica 1:104
Schüürmann G (2004) Quantum chemical descriptors in structure–activity relationships – calculation, interpretation, and comparison of methods. In: Cronin MTD (ed) Predicting chemical toxicity and fate. CRC, Boca Raton FL
Hansch C, Maloney PP, Fujita T, Muir RM (1962) Nature 194:178
Silverman RB (2004) The organic chemistry of drug design and drug action. Elsevier, Amsterdam, p 55
Medić-Šarić M, Mornar A, Badovinac-Črbjević T, Jasprica I (2004) Croat Chem Acta 1–2:367
Petrauskas AA, Kolovanov EA (2000) Perspect. Drug Discovery and Design 19:99
Eros D, Kovesdi I, Orfi L, Takacs-Novak K, Acsady G, Keri G (2002) Current Med Chem 9:1819
Schuur JH, Selzer P, Gasteiger J (1996) J Chem Inf Comput Sci 36:334
Zupan J, Vračko M, Novič M (2000) Acta Chim Slov 47:19
Hemmer CM, Gasteiger J (2000) Anal Chim Acta 420:145
Bursi R, Dao T, Wijk Tv, Gooyer Md, Kellenbach E, Verwer P (1999) J Chem Inf Comput Sci 39:861
Cramer RD, DePriest SA, Patterson DE, Hecht P (1993) The developing practice of comparative molecular field analysis. In: Kubinyi H (ed) 3D QSAR in drug design theory, methods and applications, vol 1. ESCOM Leiden 443–485
Leardi R (ed) (2003) Nature-inspired methods in chemometrics: Genetic algorithms and artificial neural networks. Elsevier, Amsterdam
Helma C (ed) (2005) Predictive toxicology. Taylor Francis, Boca Raton FL
Zupan J, Gasteiger J (1999) Neural networks in chemistry and drug design. Wiley, Weinheim
Vračko M (2005) Curr Comput-Aided Drug Des 1:73
Panek JJ, Jezierska A, Vračko M (2005) J Chem Inf Model 45:264
Spycher S, Pellegrini E, Gasteiger J (2005) J Chem Inf Model 45:200
Roncaglioni A, Novič M, Vračko M, Benfenati E (2004) J Chem Inf Comput Sci 44:300
Jezierska A, Vračko M, Basak SC (2004) Mol Divers 8:371
Shirai T, Sano M, Tamano S, Takahashi S, Hirose T, Futakuchi M, Hasegawa R, Imaida K, Matsumoto K-I, Wakabayashi K, Sugimura T, Ito N (1997) Cancer Res 57:195
Felton JS, Knize MG, Hatch FT, Tanga MJ, Colvin ME (1999) Cancer Letters 143:127
Cash GG (2001) Mutat Res Genet Toxicol Environ Mutagen 491:31
Cash GG, Anderson B, Mayo K, Bogaczyk S, Tunkel J (2005) Mutat Res 585:170
Maran U, Karelson M, Katritzky AR (1999) Quant Struct-Act Relat 18:3
Karelson M, Sild S, Maran U (2000) Mol Simul 24:229
Basak SC, Mills D (2001) SAR QSAR Environ Res 12:481
Basak SC, Mills D, Balaban AT, Gute BD (2001) J Chem Inf Comput Sci 41:671
Basak SC, Gute BD, Grunwald GD (1998) Relative effectiveness of topological, geometrical, and quantum chemical parameters in estimating mutagenicity of chemicals. In: Chen F, Schüürmann G (eds) Proceedings of the quantitative structure–activity relationships in environmental sciences. VII SETAC, Pensacola FL, p 245
Frisch MJ, Trucks GW, Schlegel HB, Gill PMW, Johnson BG, Robb MA, Cheeseman JR, Keith T, Petersson GA, Montgomery JA, Raghavachari K, Al-Laham MA, Zakrzewski VG, Ortiz JV, Foresman JB, Peng CY, Ayala PY, Chen W, Wong MW, Andres JL, Replogle ES, Gomperts R, Martin RL, Fox DJ, Binkley JS, Defrees DJ, Baker J, Stewart JP, Head-Gordon M, Gonzalez C, Pople JA (1995) GAUSSIAN 94. Gaussian Inc, Pittsburgh, PA
Vračko M, Szymoszek A, Barbieri P (2004) J Chem Inf Comput Sci 44:352
Valkova I, Vračko M, Basak SC (2004) Anal Chim Acta 509:179
Vračko M, Mills D, Basak SC (2004) Environ Toxicol Pharmacol 16:25
MOLCONN-Z (2000) Version 3.5. Hall Associates, Quincy, MA
SAS Institute(1988) Release 6.03. Cary, NC
Golbraikh A, Tropsha A (2003) J Comput-aided Mol Des 16:357
Golbraikh A (2000) J Chem Inf Comput Sci 40:414
OECD series on testing and assessment, Number 12. ENV/JM/MONO(99)2
The principles for establishing the status of development and validation of (quantitative) structure–activity relationships [(Q)SARs]. OECD document ENV/JM/TG(2004)27
Snyder RD, Smith MD (2005) Drug Discov Today 10:1119
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
About this chapter
Cite this chapter
Vračko, M. QSAR Approach in Study of Mutagenicity of Aromatic and Heteroaromatic Amines. In: Gupta, S.P. (eds) QSAR and Molecular Modeling Studies in Heterocyclic Drugs II. Topics in Heterocyclic Chemistry, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7081_026
Download citation
DOI: https://doi.org/10.1007/7081_026
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33233-6
Online ISBN: 978-3-540-33234-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)